Mark Olfson, MD, MPH currently directs several studies on the delivery of mental health services in community settings with an emphasis on the pharmacoepidemiology of psychotic and mood disorders. His research interests focus on national patterns and trends in the utilization of mental health services and quality of care. Dr. Olfson serves as Co-Director ...
Pharmacotherapy of High Risk Mood Disorders:
Prospective, parallel group, double blind, random assignment treatment study of suicide attempters with Mood Disorders, compares the effects of treatments in the prevention of suicidal behavior in these subjects.
Dr. Ruth Ottman’s research addresses the role of inherited factors in susceptibility to neurologic disorders, primarily focusing on seizure disorders. Her work on epilepsy has included assessment of familial aggregation, phenotype definition, linkage analysis and gene identification.